Intracavernosal irrigation by cold saline as a simple method of treating latrogenic prolonged erection

Journal of Sexual Medicine

Volumn 2, Issue 2, 2005, Pages 248-253

  Ateyah, Ahmed ^a   El Nashar, Abdel Rahman ^a   Zohdy, Wael ^a   Arafa, Mohammed ^a   El Den, Hatem Saad ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b MINISTRY OF HEALTH   (Egypt)

Author keywords

Intracavernosal injection; Priapism; Prolonged erection

Indexed keywords

EPHEDRINE; PAPAVERINE; PHENTOLAMINE; PHOSPHODIESTERASE INHIBITOR; SODIUM CHLORIDE; VASOACTIVE AGENT;

ADULT; ARTICLE; ASPIRATION; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COOLING; CORPUS CAVERNOSUM; EXERCISE; HIGH TEMPERATURE PROCEDURES; HUMAN; IATROGENIC DISEASE; LAVAGE; MAJOR CLINICAL STUDY; MALE; PENIS; PERINEUM; PRIAPISM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 16344385268     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2005.20235.x     Document Type: Article

References (33)

1. Levine JF, Saenz de Tejada I, Payton TR, Goldstein I. Recurrent prolonged erection and priapism as a squeal of priapism: Pathophysiology and management. J Urol 1991;145:764-7.
2. Broderick GA, Harkaway R. Pharmacologic erection: Time-dependent changes in the corporal environment. Int J Impot Res 1994;6:9-16.
3. Bondil P, Guionie R. Prolonged drug-induced erection. Treatment and prevention. Ann Urol (Paris) 1988;22:411-5.
4. Spycher MA, Hauri D. The ultrastructure of the erectile tissue in priapism. J Urol 1986;135:142-7.
5. Uchida T, Omata T, Koshiba K. Intracavernous injection of etilefrine hydrochloride in iatrogenic priapism. Hinyokika Kiyo 1986;32:1879-82.
6. Dittrich A, Albrecht K, Bar-Moshe O, Vandendris M. Treatment of pharmacological priapism with phenylephrine. J Urol 1991;146:323-4.
7. Virag R, Bachir D, Floresco J, Galacteros F, Dufour B. Ambulatory treatment and prevention of priapism using alpha-agonists. Apropos of 172 cases. Chirurgie 1997;121:648-52.
8. Bondil P. Management of drug-induced prolonged erection. Prog Urol 1994;4(5 Suppl 2):84-8.
9. Gbadoe AD, Akakpo-Vidah A, Tsolenyanu E, Messie K, Atakouma DY, Segbena AY, Vovor A, Tekou HA, Assimadi JK. Intracavernous injections of etilefrin: Its efficacy in the treatment of priapism in sickle cell patients. Presse Med 1999;28:1283-6.
10. Broderick GA, Lue TF. Priapism and the physiology of erection. AUA Update Ser, 1988; Vol. VII, lesson 29.
11. Brock G, Breza J, Lue TF, Tanagho EA. High flow priapism: A spectrum of disease. J Urol 1993;150:968-71.
12. Mathias K, Jager H, Witkowski M, Aspiotis A, Schulze H, Albrecht M. High-flow priapism following blunt perineal trauma. Interventional therapy. Radiologe 1998;38:710-3.
13. Bos SD, Buys GA. Treatment of priapism with ethyl chloride spray after failed intracavernous injection with adrenaline. Br J Urol 1994;74:677-8.
14. Mogoha GA. Priapism a historical and update view. East Afr Med J 1995;762:399.
15. Theodor VB, Susan W. On the mechanisms whereby temperature affects excitation-contraction coupling in smooth muscle. J Gen Physiol 2002;119:93-104.
16. Mitsui T, Kitazawa T, Ikebe M. Correlation between high temperature dependence of smooth muscle myosin light chain phosphatase activity and muscle relaxation rate. J Biol Chem 1994;269:5842-8.
17. Mustafa SM, Thulesius O. Cooling-induced gastrointestinal smooth muscle contractions in the rat. Fundam Clin Pharmacol 2001;15:349-54.
18. Nelson JH III, Winter CC. Priapism: Evaluation of management in 48 patients in a 22 year series. J Urol 1976;117:455-8.
19. Fowler JE Jr, Koshy M, Strub M, Chinn SK. Priapism associated with sickle cell haemoglobinopathies: Prevalence, natural history and sequelae. J Urol 1991;145:65-8.
20. Bondil P, Descottes JL, Salti A, Sabbagh R, Hamza T. Medical treatment of venous priapism apropos of 46 cases: Puncture, pharmacologic detumescence or penile cooling? Prog Urol 1997;7:433-41.
21. Lundberg PO. Priapism: Review. Scand J Sexol 2000;3:13-24.
22. Sheehan E. Management of erectile dysfunction in general practice. Irish Med J 1999;92:356-8.
23. Martin J, Lance W. Priapism. E Med J 2002;3:[epub].
24. Keskin D, Cal C, Delibas M, Ozyurt C, Gunaydin G, Nazli O, Cureklibatir I. Intracavernosal adrenalin injection in priapism. Int J Impot Res 2000;12:312-4.
25. Lee M, Cannon B, Sharifi R. Chart for preparation of dilutions of alpha-adrenergic agonists for intracavernous use in treatment of priapism. J Urol 1995;153:1182-3.
26. Muruve N, Hosking DH. Intracorporeal phenylephrine in the treatment of priapism. J Urol 1996;155:141-3.
27. Block T, Sturm W, Ernst G, Staehler G, Schmiedt E. Metaraminol in therapy of various forms of priapism. Urologe A 1988;27:225-9.
28. Tsai SK, Hong CY. Intracavernosal metaraminol for treatment of intraoperative penile erection. Post-grad Med J 1990;66:831-3.
29. Steers WD, Selby JB Jr. Use of methylene blue and selective embolization of the pudendal artery for high flow priapism refractory to medical and surgical treatments. J Urol 1991;146:1361-3.
30. de Holl JD, Shin PA, Angle JF, Steers WD. Alternative approaches to the management of priapism. Int J Impot Res 1998;10:11-4.
31. Martinez Portillo F, Hoang-Boehm J, Weiss J, Alken P, Junemann K. Methylene blue as a successful treatment alternative for pharmacologically induced priapism. Eur Urol 2001;39:20-3.
32. Martinez Portillo FJ, Fernandez Arancibia MI, Bach S, Alken P, Junemann KP. Methylene blue: An effective therapeutic alternative for priapism induced by intracavernous injection of vasoactive agents. Arch Esp Urol 2002;55:303-8.
33. Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, Nehra A, Sharlip ID, Members of the Erectile Dysfunction Guideline Update Panel, Americal Urological Association. American Urological Association guideline on the management of priapism. J Urol 2003;170(4 Part 1):1318-24.